News
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Weight-loss drugs are taking a big bite out of the food business. People taking meds like Ozempic, Mounjaro and Wegovy — originally developed to treat Type 2 diabetes — spend less on groceries ...
A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the ...
A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's blockbuster weight-loss drugs Ozempic and Wegovy, upholding the U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results